EP2364729
Mótverkandi IL-17-mótefni
Status:
EP Einkaleyfi útrunniðEP appl. date:
4.8.2005EP published:
14.5.2014EP application number:
10175150.1
EP translation filed:
29.7.2014Grant published:
15.8.2014EPO information:
European Patent Register
Max expiry date:
3.8.2025Expiry date:
3.8.2025
Title:
IL-17 antagonistic antibodies
Timeline
Today
4.8.2005EP application
14.5.2014EP Publication
29.7.2014Translation submitted
15.8.2014Registration published
3.8.2025Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Di Padova, Franco E.Address:
Birsfelden, CH
Name:
Gram, HermannAddress:
Weil am Rhein, DE
Name:
Hofstetter, HansAddress:
Riehen, CH
Name:
Jeschke, MargitAddress:
Basel, CH
Name:
Rondeau, Jean-MichelAddress:
Basel, CH
Name:
Van den Berg, WimAddress:
CB Molenhoek, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0417487Date:
5.8.2004Country:
GB
Classification
Categories:
A61K 39/395, A61P 29/00, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 28.7.2014
Expires: 3.8.2015
Payer: Árnason Faktor
Number: 11
Paid: 7.7.2015
Expires: 3.8.2016
Payer: Árnason Faktor
Number: 12
Paid: 7.7.2016
Expires: 3.8.2017
Payer: Árnason Faktor
Number: 13
Paid: 25.7.2017
Expires: 3.8.2018
Payer: Árnason Faktor
Number: 14
Paid: 25.7.2018
Expires: 3.8.2019
Payer: Árnason Faktor
Number: 15
Paid: 23.7.2019
Expires: 3.8.2020
Payer: Árnason Faktor
Number: 16
Paid: 24.7.2020
Expires: 3.8.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 23.7.2021
Expires: 3.8.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 27.7.2022
Expires: 3.8.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 26.7.2023
Expires: 3.8.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 23.7.2024
Expires: 3.8.2025
Payer: Árnason Faktor ehf.